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ABSTRACT 
Objective: To develop and validate a reverse phase high performance liquid chromatographic method for simultaneous estimation of ciprofloxacin 
and fluocinolone acetonide in bulk and pharmaceutical dosage form.  
Methods: The chromatographic separation was achieved on reverse phase Discovery Inertsil ODS3V Column, C18 (250 mm, 4.6 mm, 5 µm). The 
separation was achieved by employing the mobile phase consists of phosphate buffer (pH 4) and acetonitrile (40:60). The flow rate was 1.0 ml/min, 
at a detection wavelength of 295 nm. The proposed method was validated as per the International Council for Harmonisation (ICH) guidelines. 
Results: The retention time for ciprofloxacin and fluocinolone acetonide was found at 3.627 min and 5.037 min respectively. The proposed method 
was validated for specificity, accuracy, precision, linearity, the limit of detection (LOD), limit of quantitation (LOQ) and robustness. All validation 
parameters were within the acceptable range. The assay method was linear and found in the range from 12.5–37.25 µg/ml for ciprofloxacin and 
0.625–1.875 µg/ml of fluocinolone acetonide. The relative standard deviation (RSD) values for ciprofloxacin and fluocinolone acetonide were 0.25 
% and 0.18 %, respectively.  
Conclusion: A rapid, accurate and precise RP-HPLC method was developed for the simultaneous estimation of ciprofloxacin and fluocinolone 
acetonide in bulk and ointment formulation. The developed method was validated for specificity, accuracy, precision, linearity, the limit of detection, 
limit of quantitation and robustness according to ICH guidelines.  
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INTRODUCTION 
Ciprofloxacin (fig. 1) is a broad-spectrum antibiotic of the 
fluoroquinolone class, which is used to treat wide variety of 
infections. It is chemically 1-cyclopropyl-6-fluoro-4-oxo-7-
(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid and its 
molecular weight is 331.347 g/mol.  
 
 
Fig. 1: Structure of ciprofloxacin 
 
Fluocinolone acetonide (fig. 2) is a topical steroid used to treat the 
inflammation and itching caused by a number of skin conditions 
such as allergic reactions, eczema, seborrhea and psoriasis. It is 
chemically 4aS, 4bR, 5S, 6aS, 6bS, 9aR, 10aS, 10bS, 12S)-4b,12-
difluoro-5-hydroxy-6b-(2-hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a, 
4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho [2',1' 
:4,5] indeno[1,2-d][1,3]dioxol-2-one and its molecular weight is 
452.488 g/mol.  
An extensive literature survey revealed that there were analytical 
methods for the estimation of mentioned drugs alone [1-3] and in 
combinations [4-11]. No analytical method has been reported for the 
simultaneous estimation of ciprofloxacin and fluocinolone acetonide. 
Hence, it was thought appropriate to develop a simple RP-HPLC 
method for the simultaneous estimation of ciprofloxacin and 
fluocinolone acetonide. 
 
Fig. 2: Structure of fluocinolone acetonide 
 
MATERIALS AND METHODS 
Chemicals and reagents 
Pharmaceutically pure samples of ciprofloxacin and fluocinolone 
acetonide were obtained as gift samples from Chandra labs, Hyderabad, 
India. Orthophosphoric acid of analytical reagent grade was purchased 
from Rankem, New Delhi, India. Dihydrogen sodium phosphate, 
disodium hydrogen phosphate, acetonitrile, Milli-Q water and methanol 
of HPLC grade was purchased from Rankem, Maharashtra, India. 
Instrument 
The chromatographic technique performed on a Waters 2695 with 
PDA detector and Empower2 software, reversed-phase Discovery 
Inertsil ODS3V C18 column (250 mmx4.6 mmx5 µm), sonicator 
(LMUC-2, Labman scientific), pH meter (AD 1020, ADWA) and 
analytical balance (ER-200A, AFCOSET) were used.  
Chromatographic conditions 
The chromatographic separation was achieved on a Discovery 
Inertsil ODS 3V C18 column (250×4.6 mm, 5 μm particle size) using 
a mobile phase mixture of phosphate buffer (pH4) and acetonitrile 
(40:60), which was filtered and degassed prior to use. The flow rate 
was 1.0 ml/min and PDA detection at 295 nm. The injection volume 
was 10 μl at ambient temperature.  
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Preparation of phosphate buffer 
Accurately measured 39 ml of dihydrogen sodium phosphate (0.05 M) 
was mixed with 61 ml of disodium hydrogen phosphate (0.05 M) and 
was made up to 200 ml with distilled water. The pH of the resulted 
solution was adjusted to 4 by using orthophosphoric acid. The buffer 
solution was sonicated for 10 min to remove gases and filtered through 
0.45 µm membrane filters. 
Preparation of the mobile phase 
A mixture of phosphate buffer and acetonitrile in the ratio 40:60 % 
v/v was used as mobile phase. 
Preparation of diluent 
The diluent was prepared by taking water and acetonitrile in the 
ratio of 50:50 % v/v.  
Preparation of standard solution 
The standard stock solution of ciprofloxacin and fluocinolone 
acetonide was prepared by accurately weighing and transferring 25 
mg of ciprofloxacin and 1.25 mg of fluocinolone acetonide standards 
into a 100 ml clean dry volumetric flask, 50 ml of diluent was added, 
sonicated for 10 min and made up to the final volume with diluent. 
From the above standard stock solution, 1 ml was taken into a 10 ml 
volumetric flask and made up to the volume with diluent so as to get 
25 μg/ml of ciprofloxacin and 1.25 μg/ml of fluocinolone acetonide. 
Preparation of sample solution 
The sample stock solution of ciprofloxacin and fluocinolone 
acetonide was prepared by accurately weighing and transferring 5 g 
of ointment into a 100 ml volumetric flask. To this 10 ml of glacial 
acetic acid was added and stirred for 40 min on a magnetic stirrer 
and made up to the mark with methanol and then it was centrifuged 
for 20 min. The supernatant was collected and filtered through 0.45 
μm filters. From this 1 ml was transferred to 10 ml of volumetric 
flask and made up to the volume with diluent so as to get 25 μg/ml 
of ciprofloxacin and 1.25 μg/ml of fluocinolone acetonide. 
Validation of the developed method 
The developed method was validated for parameters such as 
specificity, linearity, accuracy, precision, LOD, LOQ and robustness 
according to ICH guidelines for analytical procedures Q2 [R1] [12]. 
Specificity  
The specificity of the method was confirmed by observing the 
interferences of blank and placebo at analyte peaks. The blank and 
placebo were prepared as per test method and injected into the 
chromatographic column and checked for the interfering peaks at 
the retention times. 
Precision 
The precision of method was verified by repeatability. Repeatability was 
checked by injecting six individual homogenous preparations of 
standard solution under the same operating conditions over a short 
interval of time (method precision). The RSD values were determined. 
Accuracyz 
Accuracy of the method was determined in triplicate at three 
concentration levels 50 %, 100 % and 150 % of target assay 
concentration. Known quantities of drug substances corresponding 
to the specified level of the label claim were added to the pre-
analyzed sample. Each set of the addition was repeated thrice. The 
recovery values were determined for each level. 
Linearity and range 
Linearity was studied by analyzing five standard solutions covering 
the range of 12.5–37.25 µg/ml for ciprofloxacin and 0.625–1.875 
µg/ml of fluocinolone acetonide. A calibration curve was plotted by 
considering concentration against the corresponding peak area and 
the correlation coefficient was determined using least square 
regression analysis.  
Limit of detection (LOD) and limit of quantitation (LOQ) 
LOD and LOQ were determined based on the standard deviation of 
the y-intercept and the slope of the calibration curve.  
LOD = 3.3 δ/S 
LOQ = 10 δ/S 
Where,  
δ = the standard deviation of the response  
S = the slope of the calibration curve  
Robustness 
Robustness is the measure of a method which remain unaffected by 
small, deliberate changes in method parameters like flow rate and 
detection wavelength. The detection wavelength was varied by±2 
nm and the flow rate was varied by±0.1 ml/min. 
RESULTS AND DISCUSSION  
Method development 
Initially, various combinations of mobile phase and stationary phase 
were tested in an attempt to obtain the best resolution for 
ciprofloxacin and fluocinolone acetonide, which lead to the 
optimization of chromatographic conditions for the estimation of 
ciprofloxacin and fluocinolone acetonide in the pharmaceutical 
dosage form. The mobile phase consisting of phosphate buffer 
whose pH adjusted to 4 with orthophosphoric acid and acetonitrile 
(40:60 %v/v), pumped at a flow rate of 1.0 ml/min, was chosen for 
method development and validation of ciprofloxacin and 
fluocinolone acetonide by RP-HPLC method. The detection was 
selected at 295 nm, using reverse-phase Discovery Inertsil ODS 3V 
C18 column (250 x 4.6 mm x 5 µm), the retention time of 
ciprofloxacin and fluocinolone acetonide was found at 3.627 min 
and 5.037 min respectively, with a total run time of 6 min which 
shows rapid elution time when compared to the retention times of 
mentioned drugs in reported methods [1,3,9]. The parameters such 
as theoretical plate count, tailing factor and resolution between the 
peaks were taken into consideration for testing system suitability 
and they were presented in table 1. From the results of system 
suitability it was found that the resolution between two peaks was 
greater than 2 and the tailing factor for both drugs was less than 2. 
The theoretical plate count was greater than 2000 for ciprofloxacin 
and fluocinolone acetonide respectively. The typical chromatogram 
for simultaneous determination of ciprofloxacin and fluocinolone 




Fig. 3: Chromatogram of ciprofloxacin and fluocinolone acetonide standard preparation 
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Table 1: Results of system suitability study 
S. No. Drug name Retention time Resolution Plate count Tailing factor Peak area 
1. Ciprofloxacin 3.627 min - 2623 1.703 2606.236 




The results of specificity shows that there was no interference of 
blank and placebo peaks at the retention times of analyte peaks, 
hence it was proved that the developed method was specific for the 
estimation of ciprofloxacin and fluocinolone acetonide. 
Precision 
The precision of the method was verified by repeatability. The 
standard solution of ciprofloxacin and fluocinolone acetonide was 
prepared at working concentration and injected six times into the 
chromatographic system. The results of precision were tabulated in 
table 2. The RSD of precision studies were calculated and found that 
the values were<2 %, hence can be concluded that the method gives 
consistently reproducible results assuring the repeatability of the 
developed method and also the method has shown good 
repeatability of ciprofloxacin and fluocinolone acetonide when 
compared to the reported methods [1-3, 10] 
Accuracy  
The results of accuracy were expressed as the percentage of analytes 
recovered by the assay. The recoveries of the drugs from a series of 
spiked concentrations were presented in table 3. According to 
statistical data, the recoveries of drugs were found to be within the 
specified range of 98-102 %. Hence, it can be concluded that the 
results of recovery studies specifies that all observed data were 
within the required range, which indicates good recovery values, 
confirming the accuracy of the developed method for the 
determination of ciprofloxacin and fluocinolone acetonide. On 
comparison of the reported method for estimation of fluocinolone 
acetonide [3], this method has shown excellent recovery. 
 
Table 2: Results of precision studies 
N Ciprofloxacin Fluocinolone acetonide 
Peak area Peak area 
Injection 1 2654 2436 
Injection 2 2651 2428 
Injection 3 2657 2436 
Injection 4 2666 2438 
Injection 5 2654 2428 
Injection 6 2646 2431 
Mean 2654.66 2432.8 
SD 6.68331 4.40075 
RSD (%) 0.25 0.18 
RSD = relative standard deviation; SD = standard deviation; Rt = retention time 
 
Table 3: Results of accuracy (recovery studies) 
Analyte Spiked level of standards Recovery (%) *Mean recovery 

























*Average of triplicate determinations 
 
Linearity and range 
The calibration curves were plotted for ciprofloxacin and 
fluocinolone acetonide in fig. 4 and 5, with concentration verses 
peak areas by injecting the prepared solutions and the obtained 
data were subjected to regression analysis using the least 
squares method. The correlation coefficient (r2) was found to be 
0.999 for both the drugs which show good linearity between 
absorbance and concentration and hence the results of linearity 
confirms that the method was said to be linear for the specified 
concentration range as it met the method validation acceptance 
criteria. 
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Fig. 4: Linearity chart of ciprofloxacin 
 
 
Fig. 5: Linearity chart of fluocinolone acetonide 
 
Table 4: Results of LOD and LOQ 
 Ciprofloxacin Fluocinolone acetonide 
LOD 0.09 µg/ml 0.17 µg/ml 
LOQ 0.27 µg/ml 0.52 µg/ml 
 
Table 5: Results of robustness 
Parameter Ciprofloxacin Fluocinolone acetonide 
Tailing Plate count Tailing Plate count 
Less flow rate (0.9 ml/min) 1.750 2543 1.321 8499 
Actual flow rate (1.0 ml/min) 1.703 2623 1.298 8592 
More flow rate (1.1 ml/min) 1.576 2456 1.268 8486 
Less wavelength (293 nm) 1.676 2578 1.326 8554 
Actual wavelength (295 nm) 1.703 2623 1.298 8592 
More wavelength (297 nm) 1.632 2543 1.271 8476 
 
Limit of detection and limit of quantitation 
The detection limits and quantitation limits of the drugs were 
presented in table 4. From the results of LOD and LOQ it was 
concluded that the developed method has good sensitivity when 
compared with reported method [9]. 
Robustness 
The results of robustness were presented in table 5. In all the varied 
chromatographic conditions no significant differences have been 
observed in system suitability parameters and were found to be 
within the limits. The results indicate that the method was 
unaffected due to deliberate changes in method parameters, which 
were expressed by system suitability parameters such as tailing and 
plate count which were found to be within the acceptance criteria 
and hence the method was found to be robust. 
CONCLUSION 
From the above experimental results, the newly developed method 
for the simultaneous estimation of ciprofloxacin and fluocinolone 
acetonide was found to be simple, precise, accurate, robust and cost-
effective and can be effectively applied for routine analysis in 
research institutions, quality control department in pharmaceutical 
industries, approved testing laboratories.  
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